Chinook Therapeutics, Inc. (KDNY)
Market Open
10 Aug, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
40. 39
+0.09
+0.2233%
$
2.71B Market Cap
- P/E Ratio
- Div Yield
3.28M Volume
- Eps
$ 40.3
Previous Close Want to track KDNY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Chinook Therapeutics, Inc. (KDNY) Statistics
Valuation metrics
Market Cap 2.71B
Enterprise value 2.63B
Trailing P/E (ttm) -14.07
Forward P/E -
PEG ratio 0.21
Price/Sales (ttm) 441.93
Price/Book (mrq) 5.88
Enterprise Value/Revenue 429.53
Enterprise Value/EBITDA -16.03
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 18.34
52-Week high 40.51
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 2 Oct 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -30.13%
Operating margin -30.2%
Operational effectiveness
Return on assets -0.32%
Return on equity -0.41%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.1
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.88
Total debt (mrq) -
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 7.59%
Book value per share (mrq) 6.87
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
